SAMAN SHAHID: Open Payments
NPI 1902484298 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,625 in 58 payments from 16 companies in 2025. Trend: 2023 $1,212 · 2024 $1,768 · 2025 $1,625
Food & beverage: $1,621Travel & lodging: $3
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $404 |
| Botanix SB Inc | 2 | $251 |
| ABBVIE INC. | 7 | $177 |
| Lilly USA, LLC | 3 | $150 |
| Amgen Inc. | 5 | $128 |
| Medimetriks Pharmaceuticals, Inc. | 5 | $102 |
| Arcutis Biotherapeutics, Inc. | 5 | $91 |
| GENZYME CORPORATION | 2 | $68 |
| Incyte Corporation | 2 | $51 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $48 |
Products named: TREMFYA, SOFDRA, SKYRIZI, OTEZLA, EBGLYSS, DUPIXENT, Zoryve, OPZELURA.
Industry payments across VA — which companies pay providers there.
